The invention relates to long-lasting anti-bacterial metallic surfaces, in particular to long-lasting anti-bacterial metallic surfaces comprising silver and/or copper doped superhard S-phase and to methods for producing the long-lasting anti-bacterial metallic surfaces.
Silver (Ag) and its compounds are some of the strongest bactericides because biologically active silver ions can inactivate bacteria by interacting with thiol groups of bacterial proteins and enzymes [1]. The first documented use of silver as an antibacterial agent can date back to 1881 when silver nitrate was used for prevention of gonococcal ophthalmia neonatorun [2]. Silver has since been researched and as a result has found some applications such as Ag-containing PMMA bone cement, Ag-containing in dwelling catheters, wound dressings and stainless steel fixation devices [3, 4]. Similarly, copper (Cu) has also been used historically throughout the world as a hygienic material because Cu also has anti-microbial effects [5].
Currently there are two methods to form Ag or Cu-containing anti-bacterial surfaces on metallic materials by: (1) alloying bulk materials surface with silver and (2) coating the substrate with an Ag or Cu-containing composite thin layer. In the first approach, ion implantation is used to dope a metal surface with Ag or Cu [6]. However, the implanted surface layer is normally <0.5 μm and hence the durability is very poor due to unavoidable wear and tear in application. In addition, ion implantation is a line-of-sight process and hence it is difficult, if not impossible, to homogeneously treat components with complex 3-D shapes.
The second approach, Ag-containing coatings, is the most researched method and some commercial processes, such as AgION™, are available to coat stainless steel surfaces. However, the AgION™ is essentially an Ag-doped polymer coating and therefore it is designed for non-tribological applications with poor durability [7]. Attempts have been made by some researchers to produce Ag or Cu-ceramic composite coatings to increase wear resistance such as PACVD deposited thin Ag-DLC composite coating [8] or thermal sprayed Ag—TiO2 composite coating [9]. However, the antibacterial effect of such thin coatings cannot last long mainly due to their low load-bearing capacity and the expected short durability; the durability of antibacterial effect of sprayed coatings is limited by their porous nature and very low bonding to the substrate. Failure of such coatings will lead to fast leaching of Ag or Cu ions and the resulted detrimental toxic effect.
It is an object of the present invention to develop novel surface engineering technologies, which can enable the above-mentioned disadvantages to be obviated or mitigated, to generate highly effective, long-lasting and minimal leaching antimicrobial metallic surfaces. This has been achieved by plasma surface co-alloying (for example by active screen plasma co-alloying) with interstitial elements (such as N, C or N/C) to form hard and wear resistant S-phase and with substitutional elements (such as Ag, Cu or Ag/Cu) to form an anti-bacterial agent reservoir for slow and continual release of Ag, Cu or both Ag and Cu for prolonged antimicrobial effect.
Broadly considered, the present invention provides novel plasma surface engineering technologies based on simultaneous surface co-alloying of stainless steel and Co—Cr alloys with both substitutional (such as Ag, Cu etc.) and interstitial (such as C, N etc.) alloying elements for the generation of novel multifunctional surfaces with high hardness, high wear resistance, good corrosion resistance and long-lasting and high antibacterial efficacy. The novel long-lasting anti-bacterial stainless steel surfaces can be used for medical devices (such as medical instruments and implants) to prevent post-operation infection, for hospital equipment to avoid hospital acquired infection and for food processing facilities to reduce food poison as well as for kitchen wares to improve hygiene.
Plasma surface alloying has been used for more than 20 years to enhance the surface properties of ferrous materials. Recently, low-temperature plasma surface alloying of austenitic stainless steels and Co—Cr alloys with such interstitial alloying elements as carbon and nitrogen has been shown to achieve improvement in the combined properties of corrosion, wear and fatigue through the formation of interstitial highly supersaturated expanded austenite, i.e. S-phase [10]. This S-phase layer is very hard (800-1200HV) and wear resistant resulting in high durability under wear conditions. Therefore, S-phase layer could be an ideal substrate for long-lasting antimicrobial surfaces. However, it is almost impossible to generate an effective antimicrobial surface layers using conventional DC or RF plasma surface alloying with Ag and/or Cu because it is impossible to form a stable Ag/Cu plasma at temperatures below 450° C. and the diffusion of substitutional Ag/Cu elements is very slow at such low-temperature.
An advanced active screen plasma (ASP) technology (
According to the present invention, there is provided a method of co-alloying stainless steel or Co—Cr alloy surfaces simultaneously with (i) N, C or C/N to form hard and wear/corrosion resistant S-phase and (ii) interstitial and substitutional alloying elements, typically with Ag, Cu or Ag/Cu to confer anti-bacterial effect, for example, by modifying plasma surface technology, such as ASP technology, with a purpose designed composite or hybrid metal screen comprising stainless steel or Co—Cr alloy mesh mixed with Ag, Cu or Ag/Cu at a temperature in the range of from 300 to 600° C. and at a pressure of from 100 to 1500 Pa for 1 to 50 hours in an atmosphere comprising N-containing, C-containing or C/N-containing gases.
Stainless steels typically have a minimum of 11 weight % chromium by mass. The chromium typically forms a passive film of chromium oxide which blocks corrosion from spreading into the metals internal structure. Typically at least 13% or up to 26% chromium is used.
The stainless steel may be ferritic or martensitic but is typically austentistic. Nickel may be added to stablise the austentistic structure of iron in the steel. Manganese may also be added to the stainless steel. Duplex stainless steels containing a mixed microstructure of austenite and ferrite may be used.
Such stainless steels are generally known in the art.
Cobalt-chrome alloys typically have high strength and may be used in gas turbines, dental implants and orthopaedic implants. Typically they have cobalt with 27 to 30 weight % chromium, 5 to 7 weight % molybdenum, less than 1% iron, less than 0.75% nickel and limits on other elements such as manganese, silicon, carbon, nitrogen, tungsten, phosphorous, sulphur and boron. The industry standard is ASTM-F75 or ASTM-F799.
The surface characteristic to be modified by the method of the present invention may be any one or more of hardness, wear resistance, corrosion resistance, fatigue strength and high anti-bacterial efficacy.
Preferably, said composite or hybrid metal screen, whole screen or part of a screen, comprises stainless steel (for surface treatment of stainless steel articles) or Co—Cr alloy (for surface treatment of Co—Cr articles) and 10-70 wt % Ag, Cu or both Ag and Cu, and may be made by hot isostatic pressing (HIPping) of stainless steel or Co—Cr micro powders with Ag/Cu nano powders at temperature between 700 and 1000° C. under a pressure of 60-120 MPa for 1-5 hours followed by machining if necessary.
Alternatively, said composite or hybrid metal screen comprising stainless steel (for surface treatment of stainless steel articles) or Co—Cr alloy (for surface treatment of Co—Cr articles) and 10-70 wt % Ag, Cu or both Ag and Cu, may be made by weaving austenitic stainless steel or Co—Cr alloy and Ag/Cu strips or by wiring austenitic stainless steel or Co—Cr alloy mesh with Ag/Cu strips.
Alternatively, a biased target source comprising Ag, Cu or Ag/Cu may be introduced into typical active-screen plasma equipment as an additional source cathode (
Preferably, said article is a medical implant, such as a joint or knee prosthesis, in which case said plasma treating is preferably carried out at a temperature in the range of from 350 to 550° C., and more preferably 400 to 500° C. At these temperatures, the method generally confers anti-bacterial efficacy, increases wear resistance and enhances corrosion resistance.
Alternatively, said article may be a medical tool (such as surgical or dental tool) or component for food processing and hospital facilities, in which case said plasma treating is typically carried out at a temperature in the range of from 350 to 550° C., more typically 400 to 500° C. At these temperatures, the method generally confers high anti-bacterial efficacy, significantly increase wear resistance but not necessarily corrosion resistance.
Typically, said treatment pressure is in the range of from 400 to 600 Pa and is more typically about 500 Pa; the duration of said treatment is in the range of from 1 to 50 hours and more typically 5 to 30 hours.
Typically, the plasma treatment is carried out in the presence of at least one unreactive gas, for example selected from hydrogen, helium, argon or other noble gas. As used herein “unreactive” relates to a gas which does not become incorporated into the article to any significant extent.
Typically, the plasma treatment is carried out in the presence of at least one reactive gas, such as an N-containing gas (e.g. N2 or ammonia) or a C-containing gas (e.g. CO or CH4). As used herein “reactive” relates to a gas which (or a part of which) does become incorporated into the article to a certain extent. Where an N-containing gas is used, the plasma treating step is typically effected at a temperature of from 350 to 450° C.
Particularly preferred gas mixtures are hydrogen and methane for carburising, nitrogen and hydrogen for nitriding, and methane, nitrogen and hydrogen for nitrocarburising.
Typically, the or each carbon-containing gas constitutes from 0.5 to 20% by volume of the total atmosphere. Typically, said reactive gas (when present) constitutes from 0.5 to 10% by volume of the total atmosphere.
Typically, the or each N-containing gas constitutes from 10 to 40% by volume of the total atmosphere. Preferably, said N-containing gas (when present) constitutes from 20 to 30% by volume of the total atmosphere. Typically the concentration of the N- or C-containing gas is substantially homogenous across the chamber.
Typically, the or each C-containing gas constitutes from 0.5 to 10% by volume of the total atmosphere. Preferably, said C-containing gas (when present) constitutes from 1 to 5% by volume of the total atmosphere.
The present invention also resides in a surface-alloyed stainless steel or cobalt-chromium based article producible or obtainable by the method of the present invention, said article characterised by having a surface region comprising (i) a thin S-phase layer embedded by Ag-, Cu or Ag/Cu and (ii) a thicker S-phase case. Preferably, said surface region has a thickness in the range of from 1 to 50 μm.
Composite or hybrid screens for use in the invention and ASP devices containing them are also published.
Embodiments of the present invention will now be described by way of example only, with reference to the accompanying drawings and specific examples hereafter.
E. coli spread plate results of:
(a) control of single S phase layer (NSS), (b) AgNSS 400 400/15, and (c) AgNSS 450/15.
Typical examples of suitable stainless steel and Co—Cr based alloys which are susceptible to the process of the present invention are summarised in Table 1. The stainless steel and Co—Cr based alloys of which the article is formed may be in the wrought, cast or PM/HIP form before the article is subjected to the process to the present invention.
In order to demonstrate the advantages of the present invention, three austenitic stainless steels, 316, 316LVM and high-N, were co-alloyed with nitrogen and Ag (nitro-silvering) or Cu (nitro-coppering) in accordance with the present invention using an active-screen plasma apparatus shown in
The treatment parameters and the sample codes are summarised in Table 2. To produce control samples, a conventional active screen plasma facility with a stainless steel mesh cylinder was also used for the low-temperature plasma nitriding (LTPN) of austenitic stainless steel surface without any antimicrobial agent (see NSS in Table 2). The articles were then subjected to SEM and TEM analysis for metallography analysis and phase identification, glow discharge spectrometry (GDS) analysis for chemical composition determination, surface hardness measurements, wear tests and antibacterial tests.
The cross-sectional micrographs in
XRD analysis revealed Ag and S-phase peaks from the ASP nitro-silvered 316LVM surfaces and Cu and S-phase peaks from the ASP nitro-coppered 316LVM surfaces. TEM studies confirmed that the multilayer structure produced by low temperature ASP nitro-silvering and nitro-coppering consisted of nano crystalline Ag (
The effect of the treatment conditions on surface microhardness profiles are depicted in
The in vitro antibacterial behaviours of stainless steel surfaces co-alloyed with Ag and N (nitro-silvering) or with Cu and N (nitro-coppering) were evaluated. The cover slip was used as control and the NSS was used as control of Ag-free or Cu-free (i.e. S-phase only).
The ASP nitro-coppered CuNSS surface was very effective in inhibiting many spectrums of bacteria, quickly and thoroughly.
To evaluate the in vitro durability of antibacterial activity of alloyed surfaces, dynamic susceptibility observation was accomplished using system washing and sterilizing that corresponded to hospital routine cleaning, and spread plate tests were carried out at intervals to evaluate viability. The antibacterial properties of surfaces after 3, 10, 30, 50, 80 and 120 times of test-cleaning cycles are shown in
Number | Date | Country | Kind |
---|---|---|---|
1211976.4 | Jul 2012 | GB | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/GB2013/051745 | 7/2/2013 | WO | 00 |